174 related articles for article (PubMed ID: 29355613)
1. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.
van Dam PJ; Daelemans S; Ross E; Waumans Y; Van Laere S; Latacz E; Van Steen R; De Pooter C; Kockx M; Dirix L; Vermeulen PB
Semin Cancer Biol; 2018 Oct; 52(Pt 2):86-93. PubMed ID: 29355613
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
[TBL] [Abstract][Full Text] [Related]
3. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
[TBL] [Abstract][Full Text] [Related]
4. Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.
Hu M; Chen Z; Hu D; Xi S; Wang D; Zhang X; Fong WP; Wen L; Cai Y; Yuan Y; Li B; Wu X; Lu Z; Chen G; Li L; Ding P; Pan Z; Wan D; Du Z; Chen M; Li Y
Front Immunol; 2022; 13():1045329. PubMed ID: 36591262
[TBL] [Abstract][Full Text] [Related]
5. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
6. Histopathological growth patterns of neuroendocrine tumor liver metastases.
Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
[TBL] [Abstract][Full Text] [Related]
7. Histopathological growth pattern evolution of tumor in VX2 liver cancer model.
Kong B; Zhou J; Wang H; Li Y; Pan Y; Zhu H; Zhang Q; Fan Q; Wang X; Zhang G
Pathol Res Pract; 2023 Apr; 244():154401. PubMed ID: 36905696
[TBL] [Abstract][Full Text] [Related]
8. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.
Latacz E; Höppener D; Bohlok A; Leduc S; Tabariès S; Fernández Moro C; Lugassy C; Nyström H; Bozóky B; Floris G; Geyer N; Brodt P; Llado L; Van Mileghem L; De Schepper M; Majeed AW; Lazaris A; Dirix P; Zhang Q; Petrillo SK; Vankerckhove S; Joye I; Meyer Y; Gregorieff A; Roig NR; Vidal-Vanaclocha F; Denis L; Oliveira RC; Metrakos P; Grünhagen DJ; Nagtegaal ID; Mollevi DG; Jarnagin WR; D'Angelica MI; Reynolds AR; Doukas M; Desmedt C; Dirix L; Donckier V; Siegel PM; Barnhill R; Gerling M; Verhoef C; Vermeulen PB
Br J Cancer; 2022 Oct; 127(6):988-1013. PubMed ID: 35650276
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
[TBL] [Abstract][Full Text] [Related]
10. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Derived Exosomes and Their Role in Cancer Progression.
Whiteside TL
Adv Clin Chem; 2016; 74():103-41. PubMed ID: 27117662
[TBL] [Abstract][Full Text] [Related]
13. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.
Wu X; Giobbie-Hurder A; Liao X; Connelly C; Connolly EM; Li J; Manos MP; Lawrence D; McDermott D; Severgnini M; Zhou J; Gjini E; Lako A; Lipschitz M; Pak CJ; Abdelrahman S; Rodig S; Hodi FS
Cancer Immunol Res; 2017 Jan; 5(1):17-28. PubMed ID: 28003187
[TBL] [Abstract][Full Text] [Related]
15. Can medical imaging identify the histopathological growth patterns of liver metastases?
Latacz E; van Dam PJ; Vanhove C; Llado L; Descamps B; Ruiz N; Joye I; Grünhagen D; Van Laere S; Dirix P; Mollevi DG; Verhoef C; Dirix L; Vermeulen P
Semin Cancer Biol; 2021 Jun; 71():33-41. PubMed ID: 32735852
[TBL] [Abstract][Full Text] [Related]
16. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
[TBL] [Abstract][Full Text] [Related]
17. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract][Full Text] [Related]
18. Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers.
Lee B; Hutchinson R; Wong HL; Tie J; Putoczki T; Tran B; Gibbs P; Christie M
Semin Cancer Biol; 2018 Oct; 52(Pt 2):241-252. PubMed ID: 29258858
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases.
Leduc S; Nguyen HL; Richard F; Zels G; Mahdami A; De Schepper M; Maetens M; Pabba A; Jaekers J; Latacz E; Bohlok A; Vanderheyden E; Van Brussel T; Boeckx B; Schepers R; Lambrechts D; Dirix L; Larsimont D; Vankerckhove S; Lucidi V; Topal B; Bachir I; Donckier V; Floris G; Vermeulen P; Desmedt C
Clin Exp Metastasis; 2024 Mar; ():. PubMed ID: 38548918
[TBL] [Abstract][Full Text] [Related]
20. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.
Hegde PS; Wallin JJ; Mancao C
Semin Cancer Biol; 2018 Oct; 52(Pt 2):117-124. PubMed ID: 29229461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]